Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2019 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of fair value on a nonrecurring basis |
| |
|
Quoted
Price in Active Markets for Identical Assets
(Level 1) |
|
|
Significant
Other Observable Inputs
(Level 2) |
|
|
Significant
Unobservable Inputs
(Level 3) |
|
|
Balance
at
June 30, 2019 |
|
|
Impairment
Loss |
|
| Patents
and other technologies |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,091,903 |
|
|
$ |
1,091,903 |
|
|
$ |
- |
|
| |
|
Quoted
Price in Active Markets for Identical Assets
(Level 1) |
|
|
Significant
Other Observable Inputs
(Level 2) |
|
|
Significant
Unobservable Inputs
(Level 3) |
|
|
Balance
at December 31,
2018 |
|
|
Impairment
Loss |
|
| Patents
and other technologies |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,255,689 |
|
|
$ |
1,255,689 |
|
|
$ |
- |
|
|
| Schedule of cash balances by geographic area |
| Country: |
|
June
30, 2019 |
|
|
December
31, 2018 |
|
| United States |
|
$ |
2,761,051 |
|
|
|
81.2 |
% |
|
$ |
1,035,802 |
|
|
|
46.0 |
% |
| China |
|
|
640,253 |
|
|
|
18.8 |
% |
|
|
1,216,485 |
|
|
|
54.0 |
% |
| Total cash |
|
$ |
3,401,304 |
|
|
|
100.0 |
% |
|
$ |
2,252,287 |
|
|
|
100.0 |
% |
|
| Schedule of reconciliation of basic and diluted net loss per share |
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June
30, |
|
|
June
30, |
|
| |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| Net
loss available to Avalon GloboCare Corp. common shareholders for basic and diluted net loss per share of common stock |
|
$ |
(4,357,224 |
) |
|
$ |
(1,294,394 |
) |
|
$ |
(8,763,040 |
) |
|
$ |
(2,775,973 |
) |
| Weighted average
common stock outstanding - basic and diluted |
|
|
75,183,354 |
|
|
|
71,979,678 |
|
|
|
74,437,336 |
|
|
|
71,122,356 |
|
| Net
loss per common share attributable to Avalon GloboCare Corp. common shareholders - basic and diluted |
|
$ |
(0.06 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.04 |
) |
|
| Schedule of the effect of including these potential shares was antidilutive |
| |
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
| |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| Stock options |
|
|
5,070,000 |
|
|
|
2,610,000 |
|
|
|
5,070,000 |
|
|
|
2,610,000 |
|
| Warrants |
|
|
1,714,288 |
|
|
|
578,891 |
|
|
|
1,714,288 |
|
|
|
578,891 |
|
| Potentially dilutive securities |
|
|
6,784,288 |
|
|
|
3,188,891 |
|
|
|
6,784,288 |
|
|
|
3,188,891 |
|
|